ORGO

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Organogenesis Holdings Inc

NASDAQ | ORGO

3.95

USD

(

0.00%

)

At Close (As of Jan 1, 1970)

$502.36M

Market Cap

-

P/E Ratio

-0.14

EPS

$6.71

52 Week High

$2.61

52 Week Low

HEALTHCARE

Sector

ORGO Chart

Recent Chart
Price Action

ORGO Technicals

Tags:

ORGO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $366M
Total Revenue $482M
Cost Of Revenue $116M
Costof Goods And Services Sold $116M
Operating Income -$1.3M
Selling General And Administrative $295M
Research And Development $50M
Operating Expenses $345M
Investment Income Net -
Net Interest Income -$1.5M
Interest Income -
Interest Expense $1.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $17M
Income Before Tax -$2.8M
Income Tax Expense -$3.7M
Interest And Debt Expense -
Net Income From Continuing Operations $861K
Comprehensive Income Net Of Tax -
Ebit -$1.3M
Ebitda $16M
Net Income $861K

Revenue & Profitability

Earnings Performance

ORGO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $498M
Total Current Assets $286M
Cash And Cash Equivalents At Carrying Value $136M
Cash And Short Term Investments $136M
Inventory $26M
Current Net Receivables $110M
Total Non Current Assets $212M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $12M
Intangible Assets Excluding Goodwill $12M
Goodwill $29M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $14M
Other Non Current Assets -
Total Liabilities $113M
Total Current Liabilities $77M
Current Accounts Payable $29M
Deferred Revenue -
Current Debt -
Short Term Debt $18M
Total Non Current Liabilities $35M
Capital Lease Obligations $43M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $43M
Other Current Liabilities $26M
Other Non Current Liabilities $894K
Total Shareholder Equity $385M
Treasury Stock -
Retained Earnings -$40M
Common Stock $13K
Common Stock Shares Outstanding $132M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $14M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $17M
Capital Expenditures $10M
Change In Receivables -
Change In Inventory -$6.2M
Profit Loss -
Cashflow From Investment -$10M
Cashflow From Financing $28M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $1.8M
Dividend Payout Common Stock $1.8M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$25M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $861K

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $366M
Total Revenue $482M
Cost Of Revenue $116M
Costof Goods And Services Sold $116M
Operating Income -$1.3M
Selling General And Administrative $295M
Research And Development $50M
Operating Expenses $345M
Investment Income Net -
Net Interest Income -$1.5M
Interest Income -
Interest Expense $1.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $17M
Income Before Tax -$2.8M
Income Tax Expense -$3.7M
Interest And Debt Expense -
Net Income From Continuing Operations $861K
Comprehensive Income Net Of Tax -
Ebit -$1.3M
Ebitda $16M
Net Income $861K

ORGO News

ORGO Profile

Organogenesis Holdings Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Organogenesis Holdings Inc. (ORGO) is a leader in regenerative medicine, specializing in innovative solutions for advanced wound care, surgical, and sports medicine markets within the United States. Headquartered in Canton, Massachusetts, the company is committed to enhancing patient outcomes through its robust portfolio of allograft products and bioactive wound care therapies. With a focus on scientific innovation and quality, Organogenesis is well-positioned to capitalize on the growing demand for effective regenerative healthcare solutions.

VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVTS
+23.51%
$10.16
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
JOBY
+2.61%
$16.70
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
PFE
-0.30%
$24.70
RR
+7.85%
$6.38
SOUN
+10.77%
$19.23
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
IREN
+8.04%
$64.58
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
NAKA
-4.05%
$0.83
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
SNAP
+3.14%
$8.02
XCH
+119.76%
$1.81
T
-1.06%
$25.59
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
HOOD
+1.03%
$140.40
HPE
+2.76%
$25.07
PMAX
+75.28%
$4.54
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
KDP
+3.02%
$26.60
RGTZ
-42.68%
$10.66
VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVTS
+23.51%
$10.16
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
JOBY
+2.61%
$16.70
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
PFE
-0.30%
$24.70
RR
+7.85%
$6.38
SOUN
+10.77%
$19.23
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
IREN
+8.04%
$64.58
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
NAKA
-4.05%
$0.83
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
SNAP
+3.14%
$8.02
XCH
+119.76%
$1.81
T
-1.06%
$25.59
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
HOOD
+1.03%
$140.40
HPE
+2.76%
$25.07
PMAX
+75.28%
$4.54
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
KDP
+3.02%
$26.60
RGTZ
-42.68%
$10.66
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.